MCID: VSC007
MIFTS: 71

Vascular Disease

Categories: Mental diseases, Gastrointestinal diseases, Cardiovascular diseases, Neuronal diseases

Aliases & Classifications for Vascular Disease

Summaries for Vascular Disease

MedlinePlus : 40 The vascular system is the body's network of blood vessels. It includes the arteries, veins and capillaries that carry blood to and from the heart. Problems of the vascular system are common and can be serious. Arteries can become thick and stiff, a problem called atherosclerosis. Blood clots can clog vessels and block blood flow to the heart or brain. Weakened blood vessels can burst, causing bleeding inside the body. You are more likely to have vascular disease as you get older. Other factors that make vascular disease more likely include Family history of vascular or heart diseases Pregnancy Illness or injury Long periods of sitting or standing still Any condition that affects the heart and blood vessels, such as diabetes or high cholesterol Smoking Obesity Losing weight, eating healthy foods, being active and not smoking can help vascular disease. Other treatments include medicines and surgery.

MalaCards based summary : Vascular Disease, also known as vascular diseases, is related to hepatic vascular disease and peripheral vascular disease, and has symptoms including vein pain, warm skin and leg cramps. An important gene associated with Vascular Disease is MTHFR (Methylenetetrahydrofolate Reductase), and among its related pathways/superpathways are Response to elevated platelet cytosolic Ca2+ and Glucose / Energy Metabolism. The drugs Methyltestosterone and Testosterone have been mentioned in the context of this disorder. Affiliated tissues include heart, endothelial and testes, and related phenotypes are cardiovascular system and homeostasis/metabolism

Disease Ontology : 12 A cardiovascular system disease that primarily affects the blood vessels which includes the arteries, veins and capillaries that carry blood to and from the heart.

Wikipedia : 72 Vascular disease is a class of diseases of the blood vessels – the arteries and veins of the circulatory... more...

Related Diseases for Vascular Disease

Diseases related to Vascular Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 425)
# Related Disease Score Top Affiliating Genes
1 hepatic vascular disease 34.4 EDN1 MTHFR NOS3 SERPINE1
2 peripheral vascular disease 34.3 ACE APOB CRP SELE SELP SERPINE1
3 retinal vascular disease 34.2 INS MTHFR VEGFA
4 buerger disease 33.4 MTHFR NOS3 SELE SERPINE1
5 thrombosis 32.6 MTHFR SELP SERPINE1 VWF
6 ischemia 32.4 ACE EDN1 NOS3 PON1 SELP VEGFA
7 vasculitis 32.4 CCL2 CRP SELE VCAM1 VWF
8 arteriosclerosis 32.2 ACE ADIPOQ APOB APOE CCL2 CRP
9 angiodysplasia 31.7 ACVRL1 VEGFA VWF
10 intermittent claudication 31.6 ACE CRP SELP SERPINE1 VEGFA VWF
11 diabetes mellitus 31.2 ACE ADIPOQ CRP INS PON1 VEGFA
12 chronic kidney failure 30.9 ACE CRP EDN1 INS VCAM1
13 aortic aneurysm, familial abdominal, 1 30.8 ACE APOE CCL2 CRP
14 homocysteinemia 30.7 CBS CRP MTHFR NOS3 SERPINE1
15 limb ischemia 30.6 ACE EDN1 NOS3 VEGFA VWF
16 arteries, anomalies of 30.6 ACE ACVRL1 ADIPOQ APOB APOE CCL2
17 antiphospholipid syndrome 30.5 MTHFR SELE SELP
18 angina pectoris 30.5 ACE CRP SERPINE1 VWF
19 body mass index quantitative trait locus 11 30.5 ADIPOQ APOB APOE CCL2 CRP IGFBP1
20 carotid stenosis 30.5 ACE APOE CRP MTHFR SELP
21 coronary heart disease 1 30.5 ACE ADIPOQ APOB APOE CRP INS
22 thrombophilia 30.4 CBS MTHFR SERPINE1 VWF
23 heart disease 30.4 ACE ADIPOQ APOB APOE CRP EDN1
24 retinal vein occlusion 30.4 CCL2 MTHFR SERPINE1 VEGFA
25 hypertriglyceridemia, familial 30.3 APOB APOE INS
26 vascular dementia 30.3 ACE APOE MTHFR PON1 VEGFA
27 peripheral artery disease 30.3 ACE APOB CCL2 CRP NOS3 SELP
28 renovascular hypertension 30.3 ACE EDN1 NOS3
29 coronary artery anomaly 30.3 ACE ADIPOQ APOB APOE CRP EDN1
30 idiopathic interstitial pneumonia 30.3 CCL2 EDN1 SERPINE1 VEGFA
31 hypercholesterolemia, familial 30.2 APOB APOE CRP INS PON1
32 cerebral atherosclerosis 30.2 ACE APOE MTHFR
33 uremia 30.2 CRP INS VWF
34 hypertensive retinopathy 30.2 ACE ADIPOQ VWF
35 ischemic heart disease 30.2 ACE APOB APOE CCL2 CRP MTHFR
36 abdominal obesity-metabolic syndrome 1 30.2 ADIPOQ INS SERPINE1
37 carotid artery disease 30.1 ACE APOB APOE CCL2 CRP SELE
38 osteonecrosis 30.1 MTHFR SERPINE1 VEGFA
39 chronic venous insufficiency 30.1 SELP SERPINE1 VCAM1
40 ischemic optic neuropathy 30.1 ACE EDN1 MTHFR NOS3
41 thrombophilia due to thrombin defect 30.1 MTHFR SERPINE1 VWF
42 sleep apnea 30.1 ACE ADIPOQ APOE CRP EDN1 INS
43 arteriosclerosis obliterans 30.1 ADIPOQ SELP VCAM1
44 pulmonary edema 30.1 ACE CRP EDN1 NOS3
45 venous insufficiency 30.1 CRP SELP SERPINE1 VCAM1 VWF
46 portal hypertension 30.1 EDN1 NOS3 VEGFA VWF
47 thrombotic thrombocytopenic purpura 30.1 SELE SELP VWF
48 apnea, obstructive sleep 30.1 ADIPOQ CRP EDN1 INS
49 varicose veins 30.0 MTHFR VEGFA VWF
50 diabetic neuropathy 30.0 ACE INS VEGFA

Graphical network of the top 20 diseases related to Vascular Disease:



Diseases related to Vascular Disease

Symptoms & Phenotypes for Vascular Disease

UMLS symptoms related to Vascular Disease:


vein pain, warm skin, leg cramps, flushing, edema, chest pain, angina pectoris

MGI Mouse Phenotypes related to Vascular Disease:

43 (show all 12)
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.41 SELP VWF SERPINE1 NOS3 VCAM1 PON1
2 homeostasis/metabolism MP:0005376 10.36 MTHFR SELP VWF SERPINE1 NOS3 VCAM1
3 growth/size/body region MP:0005378 10.32 MTHFR SELP SERPINE1 NOS3 EDN1 VCAM1
4 immune system MP:0005387 10.28 SELP VWF SERPINE1 NOS3 VCAM1 IGFBP1
5 cellular MP:0005384 10.27 VEGFA VWF SELP NOS3 IGFBP1 PON1
6 hematopoietic system MP:0005397 10.23 VWF SELP SERPINE1 NOS3 VCAM1 INS
7 mortality/aging MP:0010768 10.2 MTHFR VWF SELP SERPINE1 NOS3 EDN1
8 liver/biliary system MP:0005370 10.15 SELP SERPINE1 NOS3 IGFBP1 INS SELE
9 muscle MP:0005369 9.86 INS VEGFA EDN1 NOS3 ACVRL1 APOE
10 renal/urinary system MP:0005367 9.85 SELP SERPINE1 NOS3 INS VEGFA ADIPOQ
11 respiratory system MP:0005388 9.56 SELE VEGFA SELP SERPINE1 NOS3 ACVRL1
12 vision/eye MP:0005391 9.23 INS SELE VEGFA SELP MTHFR NOS3

Drugs & Therapeutics for Vascular Disease

Drugs for Vascular Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1208)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Methyltestosterone Approved Phase 4,Phase 3,Phase 2 58-18-4 6010
2
Testosterone Approved, Investigational Phase 4,Phase 3,Phase 2 58-22-0 6013
3
Verteporfin Approved, Investigational Phase 4 129497-78-5
4
Paclitaxel Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 33069-62-4 36314
5
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-78-2 2244
6
Menthol Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 2216-51-5 16666
7
Clopidogrel Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 120202-66-6, 113665-84-2 60606
8
Ramipril Approved Phase 4,Phase 3,Phase 2 87333-19-5 5362129
9
Ticlopidine Approved Phase 4,Phase 3,Phase 2,Phase 1 55142-85-3 5472
10
Ustekinumab Approved, Investigational Phase 4 815610-63-0
11
Exenatide Approved, Investigational Phase 4,Phase 3 141758-74-9 15991534
12
Metformin Approved Phase 4,Phase 3,Phase 2 657-24-9 4091 14219
13
Esomeprazole Approved, Investigational Phase 4,Phase 1 161796-78-7, 119141-88-7 9579578 4594
14
Famotidine Approved Phase 4 76824-35-6 3325
15
Histamine Approved, Investigational Phase 4,Phase 3,Phase 1 51-45-6, 75614-87-8 774
16
Enalapril Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 75847-73-3 40466924 5362032
17
Enalaprilat Approved Phase 4,Phase 3,Phase 2,Phase 1 76420-72-9 6917719
18
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613 2171
19
Chlorhexidine Approved, Vet_approved Phase 4,Phase 2,Phase 3 55-56-1 2713 9552079
20
Clindamycin Approved, Vet_approved Phase 4 18323-44-9 29029
21
Iodine Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 7553-56-2 807
22
Metronidazole Approved Phase 4 443-48-1 4173
23
Povidone Approved Phase 4,Phase 3 9003-39-8
24
Povidone-iodine Approved Phase 4,Phase 3 25655-41-8
25
Teicoplanin Approved, Investigational Phase 4 61036-62-2
26
Sevelamer Approved Phase 4 52757-95-6, 152751-57-0 3085017
27
Dalteparin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 9005-49-6
28
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 9005-49-6 46507594 772
29
Cilostazol Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 73963-72-1 2754
30
Ticagrelor Approved Phase 4,Phase 3,Phase 2,Phase 1 274693-27-5 9871419
31
Chromium Approved Phase 4,Phase 3,Phase 2,Phase 1 7440-47-3 27668
32
Pravastatin Approved Phase 4,Phase 3,Phase 2,Phase 1 81093-37-0 54687
33
Nifedipine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 21829-25-4 4485
34
Bisoprolol Approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1 66722-44-9 2405
35
Amlodipine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 88150-42-9 2162
36
Angiotensin II Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 68521-88-0, 4474-91-3, 11128-99-7 172198 65143
37
Hydrochlorothiazide Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 58-93-5 3639
38
Telmisartan Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 144701-48-4 65999
39
Amiloride Approved Phase 4,Phase 3,Phase 2,Phase 1 2609-46-3, 2016-88-8 16231
40
Captopril Approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1 62571-86-2 44093
41
Nitrendipine Approved, Investigational Phase 4,Phase 3,Phase 2 39562-70-4 4507
42
Chlorthalidone Approved Phase 4,Phase 3,Phase 2 77-36-1 2732
43
Simvastatin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 79902-63-9 54454
44
Nebivolol Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 152520-56-4, 118457-14-0, 99200-09-6 71301
45
Ephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1 299-42-3 9294
46
Oxymetazoline Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 1491-59-4 4636
47
Phenylephrine Approved Phase 4,Phase 3,Phase 2,Phase 1 59-42-7 6041
48
Pseudoephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1 90-82-4 7028
49
Clonidine Approved Phase 4,Phase 2,Phase 1,Early Phase 1 4205-90-7 2803
50
Spironolactone Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 1952-01-7, 52-01-7 5833

Interventional clinical trials:

(show top 50) (show all 10075)

# Name Status NCT ID Phase Drugs
1 Testosterone for Peripheral Vascular Disease Unknown status NCT00504712 Phase 4 Testosterone;0.9% saline
2 Intravitreal Aflibercept for Neovascular Polypoidal Choroidal Vasculopathy (RIVAL Trial) Unknown status NCT02092532 Phase 4 Rescue Intravitreal Aflibercept Injection
3 Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy Unknown status NCT02072408 Phase 4 aflibercept
4 Paclitaxel Eluting Balloon and Conventional Balloon for In-Stent Restenosis of the Superficial Femoral Artery Unknown status NCT01083394 Phase 4
5 Efficacy Study of Stenting, Paclitaxel Eluting Balloon or Atherectomy to Treat Peripheral Artery Disease Unknown status NCT00986752 Phase 4
6 Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part II) (DCLI-II) Unknown status NCT01173094 Phase 4
7 Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part I) Unknown status NCT01171703 Phase 4
8 Comparison of Stent and Prothesis Bypass in Superficial Femoral Artery Unknown status NCT01147419 Phase 4
9 PRedictive Factors and Changes From Treatment in Idiopathic Polypoidal Choroidal Vasuclopathy Versus Central Serous Chorioretinopathy Versus Neovascular Age Related Macular Degeneration With afLibercept Unknown status NCT02681783 Phase 4 aflibercept
10 Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy Unknown status NCT01743014 Phase 4 Ramipril;Clopidogrel
11 Early Warning and Optimization Strategy in Carotid Endarterectomy Unknown status NCT01210937 Phase 4
12 Study Effects of Ginkgo Biloba Extract on Endothelial Cell Function and Genetic Effects on the Response to Ginkgo Biloba Extract in Diabetic Patients With Stable Coronary Artery Disease Unknown status NCT01038050 Phase 4 Ginkgo Biloba Extract (GBE)
13 The Difference of Microparticles in Patients With Psoriasis Vulgaris Who Received Stelara(Ustekinumab) Unknown status NCT02693470 Phase 4 Ustekinumab
14 Evaluate the Effect of Exenatide Treatment on Coronary Artery Endothelial Function Unknown status NCT02584075 Phase 4 Byetta (Exenatide);Glucophage ( Metformin Hydrochloride)
15 Esomeprazole or Famotidine in the Management of Aspirin Related Non-Ulcer Dyspepsia Unknown status NCT00978159 Phase 4 esomeprazole;Famotidine
16 LDL-C Lowering Efficacy and Safety of Rosuvastatin 20 mg/Day to10 mg/Day in Chinese ACS(Acute Coronary Syndrome) Patients Unknown status NCT02077257 Phase 4 Rosuvastatin
17 Anti-Hypertensive Agent (ACEi) and Heart Function Improvement in Association With Rho Kinase Activity Changes in Human Unknown status NCT01069042 Phase 4 Enalapril
18 The Amputation Surgical Site Infection Trial (ASSIT) Unknown status NCT02018094 Phase 4 Co-amoxiclav;Iodine;Metronidazole;Chlorhexidine;Teicoplanin;Clindamycin
19 Graz Study on the Risk of Atrial Fibrillation Unknown status NCT01461434 Phase 4
20 How Bone is Made in Children Receiving Dialysis Unknown status NCT01799317 Phase 4 Vitamin D2
21 Safety and Efficacy Study of OmniWave Endovascular System to Treat Deep Vein Thrombosis Unknown status NCT00640731 Phase 4
22 Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis Unknown status NCT01245998 Phase 4 Dalteparin;Dalteparin
23 Lovaza Mechanisms of Action Unknown status NCT01301794 Phase 4
24 Residual Platelet Activity In Advanced Peripheral Artery Disease Unknown status NCT01627431 Phase 4 Acetylsalicylic acid;Clopidogrel
25 Platelets Induced Vasodilation, in Vitro and in Vivo Study Unknown status NCT00152646 Phase 4 placebo, aspirine, clopidogrel
26 Paclitaxel Eluting Stent or Exercise for Thigh Atherosclerosis Unknown status NCT02033135 Phase 4
27 Efficacy of Self-Expanding Nitinol S.M.A.R.T CONTROL Stent Versus Life Stent For The Atherosclerotic Femoro-Popliteal Arterial Disease Unknown status NCT01653600 Phase 4
28 Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic Events Unknown status NCT00886574 Phase 4 Cilostazol;Aspirin
29 Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy Unknown status NCT01823185 Phase 4 clopidogrel;Ticagrelor or prasugrel
30 Revascularization of Renal Artery Stenosis Versus Medical Therapy for the Treatment of Ischemic Nephropathy Unknown status NCT01023373 Phase 4 Medical treatment
31 Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCAD Unknown status NCT02008786 Phase 4 ramipril;rosuvastatin;placebo
32 COMPETE: A Clinical Evaluation of Chrono Carbostent Carbofilm™ Coated Stent Unknown status NCT00920283 Phase 4
33 The Effects of Pravastatin and Rosuvastatin on Coronary Plaques in Patients With Stable Angina Pectoris Unknown status NCT01325818 Phase 4 pravastatin, rosuvastatin
34 Effect of Nifedipine GITS in Patients With Mild-to-moderate Primary Hypertension Unknown status NCT02641821 Phase 4 Nifedipine GITS
35 BRAVE Study With Uncontrolled Essential Hypertension (BRAVE Study) Unknown status NCT02398929 Phase 4 Bisoprolol 2.5 mg;Placebo
36 Colloid Preload Versus Colloid Coload During Cesarean Deliveries Unknown status NCT02393196 Phase 4 hydroxyethyl starch (% 6 HES 130/0.4) (Voluven®);hydroxyethyl starch (%6 HES 130/0.4) (Voluven®)
37 INTERVENCION Trial Unknown status NCT02373163 Phase 4 Hydrochlorothiazide;Amlodipine;Telmisartan
38 Comparison of Single and Combination Diuretics in Low-Renin Hypertension Unknown status NCT02351973 Phase 4 Hydrochlorthiazide;Amiloride;Hydrochlorthiazide and Amiloride
39 The Efficacy of a Combination of Telmisartan/S-Amlodipine Compared With Telmisartan Monotherapy Unknown status NCT02231788 Phase 4 Telminuvo®Tab. 40/2.5mg;Telmitrend®Tab. 80mg
40 Treatment of Hypertension in Tibetan Adult Population Unknown status NCT02217852 Phase 4 Nitrendipine;Hydrochlorothiazide;Captopril,Hydrochlorothiazide;Beijing hypotensive No.0
41 Treatment of HYpertension: Morning Versus Evening Unknown status NCT02214498 Phase 4 Enalapril/hydrochlorothiazide;Placebo
42 The Short-term Efficacy of Gastrodia and Uncaria Drink in Treating Hypertension Unknown status NCT02156024 Phase 4 Gastrodia and Uncaria Drink
43 Chlorthalidone and HCTZ Impacts on Platelet Activation Unknown status NCT02100462 Phase 4 Chlorthalidone 12.5 mg;Hydrochlorothiazide 25 mg;Aspirin 81 mg
44 Multifactorial Intervention on Cardiovascular Risk Factors in Subjects With Peripheral Arterial Disease Unknown status NCT00144937 Phase 4 Stepwise therapy for dyslipidemia, hypertension and diabetes
45 The Hypotensive Effect of Metformin in Hypertensive Patients. Unknown status NCT02072382 Phase 4 Metformin;Placebo
46 Comparative Study of the Effects of Telmisartan and Nebivolol Unknown status NCT02057328 Phase 4 TELMISARTAN;NEBIVOLOL
47 Rosuvastatin for Preventing Complications in Renal Ablation Unknown status NCT01899027 Phase 4 Rosuvastatin;Placebo
48 Delayed Vasospasm After Aneurysm With the Standardization Treatment of Traditional Chinese Medicine Unknown status NCT01840761 Phase 4 herbal drug;placebo
49 Compared Efficacy and Tolerance of Two Vasopressors Used to Treat Preoperative Hypotension During Carotid Surgery Unknown status NCT01794273 Phase 4 ephedrine and phenylephrine
50 Prehypertension and Dietary Supplements - The PYRAMIDS Study Unknown status NCT01682291 Phase 4

Search NIH Clinical Center for Vascular Disease

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Cochrane evidence based reviews: aneurysm

Genetic Tests for Vascular Disease

Anatomical Context for Vascular Disease

MalaCards organs/tissues related to Vascular Disease:

38
Heart, Endothelial, Testes, Kidney, Eye, Lung, Liver

Publications for Vascular Disease

Articles related to Vascular Disease:

(show top 50) (show all 1838)
# Title Authors Year
1
A Nonsurgical Approach to Mesenteric Vascular Disease. ( 29419563 )
2018
2
Determination of hemodynamic risk for vascular disease in planar artery bifurcations. ( 29434229 )
2018
3
<i>ABCA7</i> and risk of dementia and vascular disease in the Danish population. ( 29376091 )
2018
4
Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease. ( 29310800 )
2018
5
Long-term atherosclerotic vascular disease risk and prognosis in elderly women with abdominal aortic calcification on lateral spine images captured during bone density testing: A prospective study. ( 29443425 )
2018
6
Novel concepts for the role of smooth muscle cells in vascular disease:the need for a unifying smooth muscle cell classification. ( 29408963 )
2018
7
Identifying Pain and Effects on Quality of Life from Chronic Wounds Secondary to Lower-Extremity Vascular Disease: An Integrative Review. ( 29438143 )
2018
8
Comparisons of the Framingham and Pooled Cohort Equation Risk Scores for Detecting Subclinical Vascular Disease in Blacks Versus Whites. ( 29361288 )
2018
9
Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. ( 29308539 )
2018
10
Gene polymorphisms of fibronectin rs2289202 and fibrillin 2 rs331069 associate with vascular disease, the TAMRISK study. ( 29399340 )
2018
11
Pulmonary Vascular Disease: Hemodynamic Assessment and Treatment Selection-Focus on Group II Pulmonary Hypertension. ( 29417467 )
2018
12
Evolving Mechanisms of Vascular Smooth Muscle Contraction Highlight Key Targets in Vascular Disease. ( 29452094 )
2018
13
Is Pulmonary Vascular Disease reversible with PPAR EL agonists? ( 29432661 )
2018
14
Erectile dysfunction is associated with subclinical carotid vascular disease in young men lacking widely-known risk factors. ( 29442076 )
2018
15
First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertension. ( 29348153 )
2018
16
Identifying Pain and Effects on Quality of Life from Chronic Wounds Secondary to Lower-Extremity Vascular Disease: An Integrative Review. ( 29438151 )
2018
17
Atherosclerotic vascular diseases have really the same risk factors? Comparison between large abdominal aortic aneurysm and obstructive non-coronary arterial disease. ( 28509621 )
2017
18
The combination of stem cells and tissue engineering: an advanced strategy for blood vessels regeneration and vascular disease treatment. ( 28915929 )
2017
19
Vascular disease: Benefits of population screening for vascular risk. ( 28905862 )
2017
20
Gut microbiota in vascular disease: Therapeutic target? ( 28056754 )
2017
21
Peripheral Vascular Disease: The Beneficial Effect of Exercise in Peripheral Vascular Diseases Based on Clinical Trials. ( 29098622 )
2017
22
Polyarteritis nodosa presenting as peripheral vascular disease and acute limb ischemia. ( 28397742 )
2017
23
Peripheral Vascular Disease in Patients with Diabetic Foot Ulcers - An Emerging Trend: A Prospective Study from North India. ( 28598042 )
2017
24
Vascular Endothelial (VE)-Cadherin, Endothelial Adherens Junctions, and Vascular Disease. ( 28851747 )
2017
25
The emerging role of NADPH oxidase NOX5A in vascular disease. ( 28473473 )
2017
26
Restenosis in Hemodialytic Fistulas and Chronic Kidney Disease-Associated Vascular Disease: Two Pathologies Driven by Metakaryotic Stem Cells. ( 28535522 )
2017
27
Perivascular adipose tissue inflammation in vascular disease. ( 28063251 )
2017
28
Osseointegrated Transtibial Implants in Patients with Peripheral Vascular Disease: A Multicenter Case Series of 5 Patients with 1-Year Follow-up. ( 28926380 )
2017
29
Population-based screening for vascular disease. ( 28859946 )
2017
30
Marrow-isolated adult multilineage inducible cells embedded within a biologically-inspired construct promote recovery in a mouse model of peripheral vascular disease. ( 28211362 )
2017
31
The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials. ( 28856537 )
2017
32
In Patients with Vascular Disease, Treating Sleep Apnea Does Not Reduce the Risk of Cardiovascular Events. ( 28084709 )
2017
33
Ethnic differences in the association between angiotensin-converting enzyme gene insertion/deletion polymorphism and peripheral vascular disease: A meta-analysis. ( 29354806 )
2017
34
Psoriasis-associated vascular disease: the role of HDL. ( 28911329 )
2017
35
Insidious incrementalism: The silent failure of the microcirculation with increasing peripheral vascular disease risk. ( 28236373 )
2017
36
Transverse versus Longitudinal Incisions for Femoral Artery Exposure in Treating Patients with Peripheral Vascular Disease. ( 28890060 )
2017
37
Reduced subclinical carotid vascular disease and arterial stiffness in vegetarian men: The CARVOS Study. ( 28062141 )
2017
38
Polyarteritis nodosa presenting as peripheral vascular disease and acute limb ischemia. ( 27853042 )
2017
39
Microscope-Integrated Optical Coherence Tomography Angiography in the Operating Room in Young Children With Retinal Vascular Disease. ( 28384676 )
2017
40
Re: Subclinical Vascular Disease and Subsequent Erectile Dysfunction: The Multiethnic Study of Atherosclerosis (MESA). ( 29370615 )
2017
41
Peripheral Vascular Disease and Death in Southern European Kidney Transplant Candidates: A Competing Risk Modeling Approach: Erratum. ( 28738405 )
2017
42
Social, demographic and clinical characteristics of patients suffering from peripheral vascular disease treated surgically compared to patients treated with endovascular angioplasty. ( 28905042 )
2017
43
Vascular disease in COPD: Systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine). ( 28545096 )
2017
44
Migraine and vascular disease biomarkers: A population-based case-control study. ( 28885052 )
2017
45
Pulmonary vascular disease due to left heart disease: how to achieve a more accurate approach beyond the haemodynamic phenotype. ( 28949088 )
2017
46
Serum Interleukin-23 in Polish Patients with Systemic Lupus Erythematosus: Association with Lupus Nephritis, Obesity, and Peripheral Vascular Disease. ( 29430084 )
2017
47
Calcium-induced conformational changes of Thrombospondin-1 signature domain: implications for vascular disease. ( 27485292 )
2017
48
Allopurinol and peripheral vascular disease: enough observational data to warrant interventional studies: Allopurinol and the prevention of vascular disease. ( 28968915 )
2017
49
The predictive capabilities of a novel cardiovascular magnetic resonance derived marker of cardiopulmonary reserve on established prognostic surrogate markers in patients with pulmonary vascular disease: results of a longitudinal pilot study. ( 28065166 )
2017
50
Pulmonary artery wave propagation and reservoir function in conscious man: impact of pulmonary vascular disease, respiration and dynamic stress tests. ( 28816352 )
2017